GENE ONLINE|News &
Global Diabetes Drug Market 2025: Top 10 Players and Industry Outlook
On November 6, 2025, President Trump announced agreements with Eli Lilly and Novo Nordisk to deliver “Affordable Weight-Loss Drugs for All.” Image: 123rf
Diabetes remains one of the world’s most pressing public health challenges. Aging populations, urban lifestyles, and shifting diets continue to drive prevalence in both Western and Asia-Pacific regions. In 2025, the global diabetes drug market reached a new record high, fueled by innovations in AI-driven healthcare and digital therapeutics. This report reviews the top 10 … Global Diabetes Drug Market 2025: Top 10 Players and Industry Outlook Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.
GO Prime with only $1.49 now
LATEST
Wendy Short Bartie Repositions Bristol Myers Squibb Corporate Affairs to Integrate Patient Advocacy and Healthcare Access
2026-09-14
Wendy Short Bartie Restructures Bristol Myers Squibb Corporate Affairs to Link Reputation with Business Performance
2026-09-14
Wendy Short Bartie Integrates Patient Advocacy and Public Trust into Bristol Myers Squibb Business Strategy
2026-09-14
Mycenax Teams Up with Global Partners to Expedite R&D and Market Launch of Next-Generation ADCs
2026-09-14
Chinese Bispecific Antibody Tops Keytruda in First Head-to-Head OS Win; SMA Muscle-Strengthening Therapy Approved, B7-H3 ADC Shows Promise
2026-09-14
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
